gamma-aminobutyric acid has been researched along with Menopause, Premature in 3 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
Menopause, Premature: The premature cessation of menses (MENSTRUATION) when the last menstrual period occurs in a woman under the age of 40. It is due to the depletion of OVARIAN FOLLICLES. Premature MENOPAUSE can be caused by diseases; OVARIECTOMY; RADIATION; chemicals; and chromosomal abnormalities.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Centrally active agents (eg, venlafaxine, paroxetine, gabapentin) are regarded as the most promising nonhormonal treatments for hot flashes in breast cancer survivors." | 4.84 | Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review. ( Bordeleau, L; Goodwin, P; Loprinzi, C; Pritchard, K, 2007) |
| "Women with breast cancer may experience treatment-induced menopausal symptoms or natural menopause." | 2.44 | Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review. ( Bordeleau, L; Goodwin, P; Loprinzi, C; Pritchard, K, 2007) |
| "5 mg/d, are reasonable initial dosages, and if symptoms do not improve within a week or two, the dosage can be doubled." | 2.42 | Management of hot flashes in breast cancer survivors and men with prostate cancer. ( Stearns, V, 2004) |
| "The most effective nonhormonal treatments for hot flashes include agents from the selective serotonin or noradrenergic reuptake inhibitor (SSRI/SNRI) family." | 2.42 | Management of hot flashes in breast cancer survivors and men with prostate cancer. ( Stearns, V, 2004) |
| "Hot flashes are a significant complaint among many breast cancer survivors and many men undergoing androgen deprivation therapy for prostate cancer." | 2.42 | Management of hot flashes in breast cancer survivors and men with prostate cancer. ( Stearns, V, 2004) |
| "Women affected by breast cancer (BC) will often go through menopause at an earlier age and display more frequent and severe symptoms than women who have a natural menopause." | 1.40 | Treatment of climacteric symptoms in breast cancer patients: a retrospective study from a medication databank. ( Ameye, L; Antoine, C; Paesmans, M; Rozenberg, S, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antoine, C | 1 |
| Ameye, L | 1 |
| Paesmans, M | 1 |
| Rozenberg, S | 1 |
| Stearns, V | 1 |
| Bordeleau, L | 1 |
| Pritchard, K | 1 |
| Goodwin, P | 1 |
| Loprinzi, C | 1 |
2 reviews available for gamma-aminobutyric acid and Menopause, Premature
| Article | Year |
|---|---|
Management of hot flashes in breast cancer survivors and men with prostate cancer.
Topics: Amines; Anti-Anxiety Agents; Breast Neoplasms; Complementary Therapies; Contraceptives, Oral, Synthe | 2004 |
Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review.
Topics: Amines; Antidepressive Agents; Breast Neoplasms; Complementary Therapies; Cyclohexanecarboxylic Acid | 2007 |
1 other study available for gamma-aminobutyric acid and Menopause, Premature
| Article | Year |
|---|---|
Treatment of climacteric symptoms in breast cancer patients: a retrospective study from a medication databank.
Topics: Aged; Amines; Antidepressive Agents; Antineoplastic Agents; Aromatase Inhibitors; Belgium; Breast Ne | 2014 |